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Abstract
MicroRNAs are reported to have a crucial role in the regulation of self-renewal and differen-
tiation of stem cells. Hypoxia has been identified as a key biophysical element of the stem
cell culture milieu however, the link between hypoxia and miRNA expression in stem cells
remains poorly understood. We therefore explored miRNA expression in hypoxic human
embryonic and mesenchymal stem cells (hESCs and hMSCs). A total of 50 and 76 miRNAs
were differentially regulated by hypoxia (2% O2) in hESCs and hMSCs, respectively, with a
negligible overlap of only three miRNAs. We found coordinate regulation of precursor and
mature miRNAs under hypoxia suggesting their regulation mainly at transcriptional level.
Hypoxia response elements were located upstream of 97% of upregulated hypoxia regu-
lated miRNAs (HRMs) suggesting hypoxia-inducible-factor (HIF) driven transcription. HIF
binding to the candidate cis-elements of specific miRNAs under hypoxia was confirmed by
Chromatin immunoprecipitation coupled with qPCR. Role analysis of a subset of upregu-
lated HRMs identified linkage to reported inhibition of differentiation while a downregulated
subset of HRMs had a putative role in the promotion of differentiation. MiRNA-target predic-
tion correlation with published hypoxic hESC and hMSC gene expression profiles revealed
HRM target genes enriched in the cytokine:cytokine receptor, HIF signalling and pathways
in cancer. Overall, our study reveals, novel and distinct hypoxia-driven miRNA signatures
in hESCs and hMSCs with the potential for application in optimised culture and differentia-
tion models for both therapeutic application and improved understanding of stem cell
biology.
PLOS ONE | DOI:10.1371/journal.pone.0164976 October 26, 2016 1 / 20
a11111
OPENACCESS
Citation: Agrawal R, Dale TP, Al-Zubaidi MA, Benny
Malgulwar P, Forsyth NR, Kulshreshtha R (2016)
Pluripotent and Multipotent Stem Cells Display
Distinct Hypoxic miRNA Expression Profiles. PLoS
ONE 11(10): e0164976. doi:10.1371/journal.
pone.0164976
Editor: Wan-Ju Li, University of Wisconsin-
Madison, UNITED STATES
Received: December 11, 2015
Accepted: October 4, 2016
Published: October 26, 2016
Copyright: © 2016 Agrawal et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: RK and NRF conceived the grant from
DST-UKIERI program. The funder had no role in
study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Abbreviations: HIF1A, hypoxia inducible factor 1 A;
HRM, hypoxia regulated miRNA; HREs, hypoxia
1. Introduction
Human embryonic and mesenchymal stem cell (hESCs and hMSCs, respectively) precursors
are thought to reside in physiologically hypoxic environments [1, 2]. Furthermore the physio-
logical reintroduction of clinically relevant stem cells for therapeutic application, whether
intravenously or intra-tissue will inevitably result in either acute or chronic hypoxic exposure
to the transplanted materials [3]. In vitro experimentation has established that hypoxic culture
of hESC correlates closely with increased clonogenicity, reduced spontaneous differentiation,
increased genetic stability, and transcriptional homogeneity alongside improved epigenetic
profiles [4, 5, 6, 7]. Coupled to this it is also reported that the utilisation of hypoxic culture con-
ditions in the recovery of hMSC from bonemarrow, and other tissues e.g. fat, results in dra-
matic improvements in individual stem cell yield (via Colony-Forming Unit- Fibroblastic
quantification), enhanced scale-up, and reduced transcriptional alteration (vs. normoxic cul-
tured (21% O2) cells) [8]. Of clinical relevance recent reports have suggested that ex-vivo hyp-
oxic pre-conditioning of MSCs results in enhanced survival post-transplant via resistance to
intrinsic and extrinsic death signals [3]. Taken together these investigations suggest that either
control of modulation of hypoxic signalling, or hypoxia-regulated genes could be of benefit to
the regenerative medicine industry. This identifies a need to identify novel players in hypoxic
signalling that may serve as candidates for the enhancement of stem cell based therapies.
MicroRNAs (miRNAs), a class of small non-coding RNAs, have emerged as key players in
cellular transformation and development [9]. A role for miRNAs in governing aspects of stem
cell biology as biological switches for self-renewal, fate acquisition, and differentiation has
emerged [10]. In addition to the roles detailed above it has become clear that miRNAs act as
critical mediators of hypoxia signalling [11]. Specifically, hypoxia regulatedmiRNAs (HRMs)
have been demonstrated to have roles in cell cycle modulation, apoptosis, DNA repair path-
ways, angiogenesis, metabolism,metastasis, proliferation and resistance to anticancer therapy
[12–15]. To date a single report details hypoxia-driven modulation of miRNA expression in
murine MSCs whereMiR-210, -23a and miR-21 promoted the survival of MSCs exposed to
hypoxia [16].
Surprisingly, there are as yet no reports detailing hypoxia-driven modulation of miRNA
expression in human stem cells; embryonic or adult. We therefore sought to establish whether
both embryonic (hESC) and adult (hMSC) displayed a common HRM profile in response to a
hypoxic culture setting.We have identified highly divergent HRM signatures in hESCs and
hMSCs. Importantly, target genes of these HRMs were linked to key regulatory pathways with
roles in stem cell fate determination. This work opens up several avenues for further investiga-
tion in the field of hypoxic stem cell biology. Identification of HRMs that improve stem cell
survivalmay have strong beneficial implications for regenerative and transplantation
medicine.
2. Materials and Methods
2.1. Cell culture
This study doesn't require any ethical statement. The hMSCs were isolated from commercially
sourced bonemarrow (Lonza) which does not require ethics and the hESCs were used under
approval from the UK Stem Cell Bank (UKSCB). HESCs were cultured either as describedpre-
viously (SHEF1) [17] or in defined conditions (SHEF2). SHEF1 were cultured in a mouse
embryonic fibroblast (MEF)-conditionedKnockout-DMEM supplemented with 20% Knock-
out-SerumReplacement, 1 mM L-glutamine, 1% non-essential amino acids, 100 mM β-mer-
captoethanol (all Life Technologies, Paisley, UK), and 4 ng/mL bFGF (Sigma, Poole, UK). Cells
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were expanded on flasks coated with a Matrigel (BectonDickinson, Bedford,MA) substrate in
preconditionedmedia. Prior to use, conditionedmedia was further supplemented with an
additional 4 ng/mL bFGF. Cells were passaged enzymatically at 70–80% confluency using
Trypsin/EDTA and media changed daily. SHEF2 were cultured in Essential 8 definedmedium
on vitronectin-coated tissue culture plates. At 70–80% confluency, cells were passaged with 0.5
mM EDTA treatment; following passage media was changed at 48 hours and daily thereafter.
All reagents from Life Technologies (Paisley, UK) unless otherwise stated. Cells were main-
tained in standard incubators at 37°C in a humidified 5% CO2 atmosphere. For maintenance of
hypoxic conditions, cells were grown continuously for10 passages or approximately 6 weeks
in a hypoxia workstation (SCI-tive, Ruskinn, UK) at 2% O2, 5% CO2, 37°C. Cells were used at
passages 61–63 for RNA extraction.
Human MSCs were isolated from commercially sourced bone marrow aspirate (Lonza,
USA) retrieved from the iliac crest following detailedmethodologypublished in Kay et al 2015
[8]. Briefly, whole bone marrow was seeded at a density of 105 mononuclear cells (MNC)/cm2
on 10 ng/mL fibronectin-coated flasks in each condition (21% O2 and 2% O2). MNC were
seeded into DMEM (4.5g/L) 5% FBS, 100 U/mL penicillin, 100 U/mL streptomycin, 1%
NEAA, and 1% L-Glutamine (all Lonza, UK). Penicillin and streptomycin were included ini-
tially to counteract the inherent infection risk associated with the culture of primarymaterials.
After 7 days half of the culture mediumwas replaced with fresh antibiotic-freemedia; after 14
days media was replaced completely again without the inclusion of antibiotic. At day 21 the
cells were harvested at passage 0 for RNA isolation. For maintenance of hypoxic conditions,
cells were recovered and cultured continuously in a hypoxia workstation (SCI-tive, Ruskinn,
UK) at 2% O2, 5% CO2, 37°C prior to RNA extraction.
2.2. Cell lysis and homogenisation
In brief, cell monolayers were washed with PBS and lysed using the RLT lysis buffer from the
RNeasy minikit (Qiagen, UK). A cell scraper was used to detach cells from the culture flask and
the resulting lysate transferred to a QIAshredder spin column (Qiagen) for homogenisation.
The QIAshredder column was centrifuged for 2 minutes at 13200 RPM, the column removed
and the lysate stored at -80°C until required.
2.3. RNA extraction
RNA was extracted from cell lysates according to manufacturer’s instructions using the RNeasy
Minikit. The concentration and purity of RNA extractedwas measured using a NANODROP
2000c spectrophotometer (Thermo Scientific) and RNA was subsequently stored at -80°C.
2.4. Microarray expression profiling and analysis
MiRNA expression data was generated from the AffymetrixGeneChip1 miRNA arrays via
iLife Discoveries. Normalization was performedwith Expression Command Console and sub-
sequent analysis with GeneSpring GX 11.5 Software. A ± 2 fold change cut off was used for
identifying differentially expressedmiRNAs (S1 Table).
2.5. Prediction of HREs in the promoter of miRNAs
HRE detectionwas performedwithin the promoter region (5KB upstream of the 5’end of the
pre-miRNA) of candidate miRNAs. The upstream region was extracted from Ensembl genome
browser. HRE consensus sequences are as described elsewhere [11]. The following consensus
sequences were used to search for HREs: Q3-GNNKACGTGCGGNN, Q5-NGTACGTGCNGB,
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Q6- NRCGTGNGN, (N—Adenine / Guanine / Cytosine / Thymine, B—Guanine / Thymine /
Cytosine, R—Guanine / Adenine) using python 3.2 software. HIF1A binding sites were identi-
fied within promoter regions using the PROMO prediction program [18, 19].
2.6. Chromatin Immunoprecipitation-qPCR (ChIP-qPCR)
The Low Cell ChIP Kit (M/S Diagenode, Belgium) protocol was followed with someminor
modifications. Briefly, cells were cross-linked using 1% formaldehyde in PBS with the reaction
stopped after 10 min using 100 μl of 125 mM glycine. The cells were then washed with PBS fol-
lowed by suspension in ChIP buffer. The chromatin was next fragmented using Diagenode
Bioruptor plus. Fragmented chromatin (equivalent to 1 million cells) was immunoprecipitated
using HIF-1 antibody (M/s Santa Cruz) and IgG antibody (M/s Abcam, USA) as per Low Cell
ChIP kit guidelines. After overnight incubation, the beads were washed and immunoprecipi-
tated and input DNAs were proceeded for DNA isolation using IPure kit (M/s Diagenode, Bel-
gium) following the manufacturer’s instructions. qPCR reactions were performed using 3μl of
DNA in a CFX96™ Real time system (BIO-RAD) using SyBr green dye with primers encom-
passing HREs in promoter sequence of various miRs and ACTB (negative control). Enrich-
ment was expressed as the percent input by using the following formula: Percentage of total
input = 100×2^[Ct (ChIP)—(Ct input—log2 (input dilution factor)]
2.7. Target prediction and pathway analysis
Probable targets for differentially regulatedmiRNAs were identifiedwith the DIANA-Mi-
croT-CDS prediction program [20]. DIANA-mirPath was used for pathway analysis of differ-
entially expressedmicroRNAs in response to hypoxia [21]. A list of probable targets was
determined via the inverse correlation of expression with the differentially expressedmiRNA
matched to previously published gene expression data of hypoxic cultured hESC and hMSCs
under identical conditions [22, 8].
2.8. MiRNA quantitation
Candidate miRNAs were reverse transcribed to cDNA using specific stem-loop RT primers (S2
Table). Quantitation was performed on a CFX96™ real time system (Bio-RAD) using cDNA
specific forward primer and a universal reverse primer as listed in S2 Table. RNU6B was used
for normalization in all the samples. A list of primers and sequences is given in S2 Table.
3. Results
3.1. MicroRNA signature of hypoxia in human embryonic and
mesenchymal stem cells
Previous studies, including ours, have describedhypoxia-induced differential gene expression
in hESCs and hMSCs [22, 23, 8], but hypoxia-drivenmiRNA regulation in hESCs and hMSCs
remains undescribed thus far. SHEF1 (hESCs) cells and hMSCs were exposed continuously to
normoxia (21% O2) or hypoxia (2% O2) followed by RNA extraction and determination of
miRNA expression using AffymetrixGeneChip1 miRNA Arrays.
Comparison of normalized normoxic and hypoxic hESCs miRNA profiles identified differ-
ential expression of 50 miRNAs (>2 fold difference, p<0.05); 31 up-regulated and 19 down-
regulated in response to hypoxia (Fig 1a and 1b, S1 Table). Upregulation (miR-4271,-4306,
-520a-5p, -148b-3p and miR-146a-5p) and down regulation (miR-92a-1-5p, -92a-2-5p,-34c-
5p, -138-5p and miR-4304) were checked in the array-based line (SHEF1) and in a second inde-
pendent line (SHEF2) using quantitative stem loop RT-PCR (Fig 1c and 1d, S1a and S1b Fig).
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Fig 1. The miRNA signature of hypoxia in hESCs. Hierarchical clustering of hypoxia (a) induced and (b)
down-regulated miRNAs (> 2 fold, p<0.05) in response to hypoxia (2% O2) in SHEF1 hESC. Quantitative
RT-PCR data of upregulated (c) mature miRNAs & (e) pre-miRNAs and downregulated (d) mature miRNAs &
(f) pre-miRs of HRMs in SHEF1 cell line. Graphical data points in c, d, e and f represent mean ± S.D. of a
minimum of three independent experiments. (*P>0.01 and <0.05, **P<0.01).
doi:10.1371/journal.pone.0164976.g001
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However, while stem loop qRT-PCR results confirmed the down-regulation of miR-92a-1-5p,
miR-92a-2-5p and miR-34c-5p, the level of miR-4304 remained largely unaffected (Fig 1d, S1b
Fig).
To explore uniformity of hypoxic miRNA expression modulation in stem cell populations
we next explored hMSC isolated from bonemarrow. We identified 76 differentially expressed
miRNAs in hMSC (35 up-regulated and 41 down-regulated) in response to hypoxia (Fig 2a
and 2b, S1 Table). Up-regulated (miR-138-5p, -195-5p, -379-5p, -181a-2-3p, and miR-629-5p)
and down-regulated (miR-1246, -4485, -3175, and miR-663a) miRNA expression was con-
firmedwith quantitative stem loop RT-PCR in hMSC derived RNA from two independent
donor bone marrow samples (Fig 2c and 2d, S2a and S2b Fig). We next checked whether
HRMs are affected by hypoxia at the transcriptional level or due to aberrations in miRNA pro-
cessing at post-transcriptional level. For this, we first checked the levels of miRNA processing
factors—Drosha and DICER under normoxia and hypoxia. We found that levels of both
miRNA biogenesis factors are downregulated under hypoxia in hESCs and hMSCs (S1c and
S2c Figs). We then checked the levels of corresponding pre-miRNAs under normoxia and hyp-
oxia and found their regulation was consistent with their mature counterparts in both stem cell
types suggesting that the hypoxic induction of these miRNAs was mainly at the transcriptional
level (Figs 1e and 1f and 2e and 2f).
Taken together the hypoxic miRNA profiles of hESCs and hMSCs were largely distinct with
only miR-25-3p (upregulated), mir-1275 and miR-23a-5p (both downregulated) overlapping
between the two stem cell populations. Further evidence of distinct behaviour was noted in
relation to miR-138-5p which was downregulated and upregulated by hypoxia in hESC and
hMSC, respectively.
3.2. Hypoxic regulation of miRNA clusters in hESCs and hMSCs
We next sought to determine co-regulation of miRNA clusters by hypoxia. To determine the
overall trend of differential expression within the miRNA cluster, we considered all miRNAs
showing>±1.5 fold change. We identified 3 miRNA clusters which contained 19 up-regulated
miRNAs while a further 6 miRNA clusters contained 15 down-regulatedmiRNAs in hESCs
(Fig 3a). The miR-512/519a cluster was highly represented containing 14 upregulated miRNA
while 2 members of the miR-17/92 cluster and its paralogs miR-106a/363 and miR-106b/25
showed down-regulation in hypoxic hESCs. In the same manner, 25 up-regulatedmiRNAs lay
within 9 miRNA clusters in hMSCs while 7 members of the miR-379/656cluster and 3 mem-
bers of the miR-532/502 cluster showed up regulation (Fig 3b).
Further evidence of the distinct hESC and hMSCHRM profiles emerged via miRNA clus-
ters- miR-379/656, mir-532/502, miR-17/92 and its paralog miR-106b/25 being downregulated
by hypoxia in hESCs while conversely up-regulated in hMSCs. For instance miR-17/92 cluster
members were upregulated in hMSC (miR-106b-5p and miR-25-3p) but downregulated (miR-
93-3p and miR-25-5p) in hESCs (Fig 3c). This suggests preferential induction of distinct mem-
bers of the same cluster by hypoxia in developmentally and potency distinct stem cell types.
3.3. Hypoxia inducible factors (HIFs) and putative roles in miRNA
induction
Many hypoxia regulated transcripts contain consensus HIF responsive elements (HRE) in their
promoter regions which promote HIF1/HIF2 binding and induction of transcription [11]. The
5 kb region upstream of HRMs was therefore examined for the presence/absence of the HRE
consensus sequence. Of the identifiedHRM’s 97% of upregulated species contained either Q3
or Q5 consensus sequences at >0.75 (S3 Table). Further analysis revealedHIF1A binding site
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Fig 2. The miRNA signature of hypoxia in hMSCs. Hierarchical clustering of hypoxia (a) induced and (b)
down-regulated miRNAs (> 2 fold, p<0.05) in response to hypoxia (2% O2) in human bone marrow derived
MSCs. Quantitative RT-PCR data of upregulated (c) mature miRNAs and (e) pre-miRNAs and
downregulated (d) mature miRNAs and (f) pre-miRs of HRMs in human bone-marrow derived MSCs. The
graphical data points in c, d, e and f represent mean ± S.D. of at least three independent experiments.
(*P>0.01 and <0.05, **P<0.01).
doi:10.1371/journal.pone.0164976.g002
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consensus sequences in 12 and 17 upregulated miRNAs for hESC and hMSC, respectively,
where strong scores (0.85) suggestedHIF1A regulation (Fig 4).
HIF binding to candidate HREs was examined by CHIP-qPCR in hESCs and hMSCs under
normoxia and hypoxia. In hypoxia treated hMSCs, direct HIF binding to the cis-elements was
observed for 5/7 miRNAs tested (while in hypoxic hESCs the HREs present upstream of miR-
146a and miR-602 were found to be bound by HIF-1 (Fig 5a and 5b). HIF binding to the pro-
moter elements of candidate miRNAs was inhibited in normoxic conditions in both types of
stem cells (Fig 5c and 5d). This suggests that the induction of specificmiRNAs under hypoxia
is HIF mediated in hESCs and hMSCs.
The presence of HRE and HIF1A-specific binding site consensus sequences led us to
hypothesize on the existence of a feedback loop in hypoxia signal transduction in hESCs and
hMSCs.We therefore next sought to identify which of our HRMs was predicted to target HIF
directly or via targeting genes that regulate HIF levels. The hESC (miR-520a-5p, -4271, and
miR-4306) and hMSC (miR-138-5p, -140-3p, -210 and miR-1271) upregulated HRMs were
predicted to target HIF pathway inhibitors; HIF1A inhibitor (HIF1AN) and HIF3A, respec-
tively, creating a prospective HIF pathway positive feedback loop. In contrast, downregulated
HRMs in hESCs (miR-92a-1-5p and miR-92a-2-5p) were predicted to target HIF1A directly
creating a negative feedback loop to suppress HIF signal transduction. Overall, this suggests
Fig 3. Co-regulation of miRNA clusters by hypoxia. Tables representing hypoxia up-regulated and down-regulated miRNA clusters in (a) SHEF1
cells, (b) bone marrow derived MSCs, and (c) preferential induction of the distinct members of the same cluster by hypoxia.
doi:10.1371/journal.pone.0164976.g003
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PLOS ONE | DOI:10.1371/journal.pone.0164976 October 26, 2016 8 / 20
Fig 4. HREs location in HRM promoters. The 5kb upstream region of hypoxia induced miRNAs was screened for the
presence of HREs in their promoter using PROMO prediction program. Figure showing relative positions of predicted HREs
in the promoter region.
doi:10.1371/journal.pone.0164976.g004
miRNA Signature of Hypoxia in Stem Cells
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Fig 5. Transcriptional regulation of HRMs. ChIP assay was performed using antibodies against HIF-α or IgG to
confirm the binding of HIF-1 α on the putative HREs in the promoters of specific HRMs. qPCR data showing fold
enrichment of bound chromatin compared with input in hMSCs grown in (a) hypoxic or (c) normoxic conditions and
hESCs in (b) hypoxic and (d) normoxic conditions. (e) Putative hypoxia signal transduction feedback loop in hESC
and hMSCs.
doi:10.1371/journal.pone.0164976.g005
miRNA Signature of Hypoxia in Stem Cells
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that specificHRMsmay operate as a check and balance system to regulate HIF levels during
exposure to hypoxia (Fig 5e).
3.4. MiRNA: gene networks
Utilising previously generated transcript array data sets for both hESC and hMSC in nor-
moxia/hypoxia we next sought to determinemiRNA:gene correlations by identifying the
inverse correlation of expression in miRNA:target pairs [22, 8]. Target identification via
DIANA-miRPath analysis revealed 107 and 211 differentially expressed genes in hESC and
hMSC, respectively, of which five were commonly up-regulated (ERBB receptor feedback
inhibitor 1 or ERRFI1, Insulin-like growth factor binding protein 5 or IGFBP5, Noggin or
NOG,Natriuretic peptide B or NPPB and Protein tyrosine phosphatase receptor type B or
PTPRB (Fig 6a). Of these only IGFBP5 revealed co-associationwith downregulatedmiR-92a-
2-5p (in hESC) and downregulatedmiR-3175,-3135b,-4651 (in hMSC). However, we noted
substantial overlap of predicted target transcripts of our HRMs and the hypoxia gene expres-
sion profiles (Fig 6b and 6c). We next measured the expression levels of the target transcripts
identified in Fig 6b and 6c by qPCR to determine their inverse correlation with HRMs, in both
culture settings. Notably, most of the tested genes showed a good inverse correlation with their
correspondingmiRNAs (S3 Fig).
3.5. Pathway analyses
Finally we explored pathways enriched by the differentially expressed miRNA target genes in
both hESCs and hMSCs. This identified strong associations with the HIF-1 signalling pathway
(p = 2.40E-11) for hESC, pathways in cancer (p0.000975) for hESC and hMSC, and cytokine-
cytokine receptor interaction pathway (p = 0.001933) for hMSCs (Fig 7a and 7b and S4 and S5
Tables). The miRNA:target gene interaction network for cytokine-cytokinereceptor pathway is
shown in Fig 7c.
4. Discussion
In the 15 years since the first demonstration of hypoxic regulation of miRNA expression in a
range of cancer cell lines, the hypoxia: miRNA correlation has becomewidely accepted. Several
HRMs have now been shown to be critical regulators of hypoxic signal transduction by regulat-
ing cellular properties such as apoptosis, proliferation, metabolism, angiogenesis, DNA repair
and stemness [12–15]. While some HRMs have emerged as promising prognostic markers,
others are under pre-clinical trials as novel targets for cancer therapy [24, 25]. Surprisingly the
link between hypoxia and miRNA expression has not been robustly shown thus far in human
stem cells. Our study identifies for the first time the hypoxic miRNA signature in two distinct
human stem cell types–hESCs and hMSCs and describes divergence of HRM regulation
therein.
A number of miRNA species have been identified in previous studies as having roles in
determining hESC biology. These include miR-145 (pluripotency), -148b, -146a (differentia-
tion), -302 (BMP signalling and DNA repair), -195 (apoptosis), -372 (cell division) and miR-9
(migration) [26–31]. Couple to this a number of publications have characterised the range of
miRNAs expressed by hESC under standard culture conditions and in agreement with those
we noted that three of the top ten upregulated miRNAs in hESCs (miR-4271,-4306, and miR-
148b-3p), and members of the miR-512/519a and miR-302b/367 cluster are highly expressed
in undifferentiated hESCs [32,33]. Within the miRNAs upregulated by hypoxia in hESC a
number have had hypothetical or evidenced targets identified thus far. These include NOG
(miR-148b-3p), Jumonji domain containing 3 or JMJD3 (miR-146a-5p), Myocardin or
miRNA Signature of Hypoxia in Stem Cells
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Fig 6. Target identification of hypoxia regulated miRNAs. (a) Venn diagram of up and down-regulated genes
in response to hypoxia in hESC and hMSCs. (b, c) Putative targets HRMs based on the inverse correlation of their
expression with previously published hypoxia-induced differential gene expression of hESCs and MSCs,
respectively, under identical conditions.
doi:10.1371/journal.pone.0164976.g006
miRNA Signature of Hypoxia in Stem Cells
PLOS ONE | DOI:10.1371/journal.pone.0164976 October 26, 2016 12 / 20
Fig 7. Pathway analysis of hypoxia regulated miRNAs. Pathway association of up and down-regulated HRM
in hESC and hMSCs, (a, b) respectively. A figure showing miRNA:target gene interaction network for cytokine:
cytokine receptor pathway of MSCs drawn using Cytoscape software (c). The green colour indicates up-
regulation whereas the red colour refers to down-regulation.
doi:10.1371/journal.pone.0164976.g007
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MYOCD (miR-4271, -150-5p, -146a-5p, -524-5p and miR-375) and Transmembrane protein
64 or TMEM64 (miR-548a-3p, -128 and miR-302d-3p) [34–37]. A number of downregulated
HRMs have also been described elsewhere where their targets frequently have roles in inhibi-
tion of differentiation or the differentiation state. These include NANOG (miR-134), Retinoic
acid receptor gamma or RARg (miR-34c) [38, 39]. Similarly, in embryoid bodies, hypoxia
downregulatedmiRNA clusters- miR-17/92 or its paralogs miR-106a/363 or miR-106b/25
have been shown to be upregulated [33]. The miR-17-92 cluster specifically has been shown to
target the HIF1A transcript and thus inhibit hypoxia signalling [40]. Taken together it is appar-
ent that up-regulatedmiRNAs in hypoxic hESCs correlate with inhibition of differentiation
whereas down-regulatedmiRNAs act in the converse manner.
Similarly, miRNAs have been shown to play important roles in the regulation of hMSC biol-
ogy. MiRNAs such as miR-335, -21, -146a-5p, -377, -494, -141, -10a, -138-5p, -140, -17-5p,
-143/145, -302 and miR-210 have been identified as pivotal players in governing specific
aspects of hMSC biology related to proliferation, migration, differentiation, angiogenesis,
aging, and apoptosis [41–52, 16]. A number of these have been identified here as HRMs. This
includes miR-138-5p, miR-140, miR-17-5p and members of miR-143/145 cluster as upregu-
lated HRMs which have been described elsewhere as having a role in suppression of hMSCs
differentiation [48–51]. Of note are the upregulated HRMs predicted to target Bonemorphoge-
netic protein 2 or BMP2; miR-106b-5p,-106a-5p and miR-20a-5p, whose repression has
recently been associated with enhanced hMSC yields in hypoxic conditions and inhibition of
chondrogenesis [8, 53]. Other upregulated HRMs and their targets include Sushi, vonWilleb-
rand factor type A, EGF and pentraxin domain-containing protein 1 or SVEP1 (miR-493-5p,
-497-5p, -339-5p and miR-27a-3p), TGF-β/BMP signalling or Smads (miR-23b/24 cluster-
miR-23b, -27b, -24-1)), and PR domain zinc finger protein 1 or PRDM1 (miR-30a-5p, -30c-5p
and miR-30d-5p) [54]. DownregulatedHRMs were striking in that for the most part they dis-
played an associated lack of known targets in hMSC biology but miRs- miR-1246, -4484,
-1909-3p, -3135b and miR-940 are known to target Nuclear factor 1 B-type or NFIB which
plays a role in the promotion of cortical development and neuronal differentiation [55].
The largely distinct HRM profiles observedbetween hESC and hMSC illustrate the likely
existence of divergent hypoxia signalling pathways in these two cell types. This concept is
underlined by a comparison of the hypoxia induced transcriptomes in hESC and hMSCwhich
bear little resemblance to each other. Intriguingly we noted that the canonical upregulated
HRM,miR-210 though induced in hMSC, in agreement with other studies [16, 56], was not
noted in hypoxic hESC. As miR-210 has been found to be hypoxia-inducible in a wide range of
cancer cell lines studied its absence from the list of HRMs of hESCs is intriguing [56]. Overall
the hESC upregulated HRMs are unique at this time and have not been described as hypoxia
regulated thus far. Conversely a number of previously describedupregulated HRMs including
miR-138, -195, -181a-2-3p, -485-3p, -210, 17-5p, -27a/b were also upregulated in hypoxic
hMSC [56, 57, 58]. Overall, and reflective of the divergent HRM profiles, it is likely that
miRNA play important roles in governing hypoxic stem cell behaviour.
We also noticed that hypoxia based regulation of most of these HRMs is mainly at transcrip-
tional level. The appearance of HIF1A binding site consensus sequences in the majority of
HRM promoter sequences coupled to predicted targets including HIF or HIF regulating genes
was suggestive of the existence of a feedback-loop in HIF signalling. The cell type specific upre-
gulated miRs (miR-520a-5p, -4271 and -4306 for hESCs and miR-140-3p, -210, -485 and -1271
for hMSCs) were predicted, or previously experimentally validated, to target HIF pathways
inhibitors-HIF1AN and HIF3A while downregulatedmiRNAs (miR-138-5p, -92a-1-5p and
miR-92a-2-5p in hESCs) were predicted to target HIF1A [56, 58]. The presence of an HRM-
driven feedback loop in HIF signalling has been suggested elsewhere via miRNAs such as miR-
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210, -485, -155 and miR-429 [56, 58, 59, 60] but not in relation to stem cell biology. However,
we do acknowledge that a role for other transcription factors such as Nuclear factor kappa B or
NFĸB, cAMP response element- binding protein or CREB, Activator protein-1 or AP-1, Speci-
ficity protein-1/3 or SP-1/3 etc. cannot be dismissed for the HRMs which do not show the con-
sensus HRE sequences in their upstream region [61]. Alternatively, it remains possible that
epigenetic regulation of the HRMs is occurring via hypoxic activation of methyl transferases
resulting in induction of expression [62]. Coupled to above it was apparent that HRMs in
hESCs had a predicted role in HIF signalling via regulation of other hypoxia associated genes
(S4 Fig). Several hypoxia-induced genes with roles in HIF signalling such as cyclin dependent
kinase inhibitor 1 A or p21 (CDKN1A), Serine protease inhibitor or SERPINE and 6-phospho-
fructo-2-kinase/fructose-2,6-bisphosphatase 3 or PFKFB3 showed inverse correlation of
expression with the HRMs predicted to target them [63, 64, 65].
Two further pathways enriched in gene ontology analyses of the HRM target genes were
cytokine: cytokine receptor (hMSCs) and pathways in cancer (hESCs and hMSCs). In confir-
mation of our findings previous reports have describedoxygen-dependent expression of cyto-
kines and linked them with proliferation and differentiation of hMSCs [8, 66]. A role for
HRMs in cytokine expression modulation has also been demonstrated for BMP2 (miR-106b,
-20a, and miR-106a), Zinc finger and BTB domain containing 16 or ZBTB16 (miR-1271, miR-
342), and Chemokine (C-X-Cmotif) ligand or CXCL3,6, and 8 (miR-106a/b, -20a, -493 and
miR-425) via the HRMs indicated [49, 67, 68]. Of particular note, and in agreement with the
scanty overlap in hypoxia-induced gene expression, we observeddistinct patterns of associa-
tion with pathways in cancer for hESC and hMSC virtually bisecting the associated target car-
toon (S5 Fig). As indicated earlier this is highly suggestive of distinct HRM response and
behavioural profiles in these two classes of stem cells; pluripotent and multipotent.
Overall, our findings add richly to the growing body of data surrounding hypoxic stem cell
biology for both hESCs and hMSCs. In consideration of the strong influence of hypoxia on
stem cell self-renewal and differentiation the regulatory and functional characterization of hyp-
oxia regulatedmiRNAs or genes may provide strategies to design novel cellular therapies for
regenerative medicine.
Supporting Information
S1 Fig. qRT-PCR data of (a) up-regulated and (b) down-regulatedHRMs in SHEF2.
QRT-PCR data showing levels of Drosha and DICER in hESCs grown in normoxia and hyp-
oxia (c). Graphical data points in a, b and c represent mean ± S.D. of a minimum of three inde-
pendent experiments. (P>0.01 and<0.05, P<0.01).
(TIF)
S2 Fig. Quantitative RT-PCR data of (a) up-regulated and (b) down-regulatedHRMs in a dif-
ferent human bone-marrow derivedMSCs. QRT-PCR data showing levels of Drosha and
DICER in hMSCs grown in normoxia and hypoxia (c). Graphical data points in a, b and c rep-
resent mean ± S.D. of a minimum of three independent experiments. (P>0.01 and<0.05,
P<0.01).
(TIF)
S3 Fig. qRT-PCR data showing inverse correlation of expression of (a) down-regulatedand
(b) up-regulatedpredicted target genes of HRMs in hESCs and similarly for hMSCs (c)
downregulatedand (d) upregulated.Graphical data points in a-d represent mean ± S.D. of a
minimum of three independent experiments. (P>0.01 and<0.05, P<0.01).
(TIF)
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S4 Fig. Pathway analysis of hypoxia regulatedmiRNAs. A figure showing miRNA:target
gene interaction network for HIF-1 signalling pathway in hESCs drawn using Cytoscape soft-
ware. The green color refers up-regulation while the red color refers down-regulation.
(TIF)
S5 Fig. Pathway analysis of hypoxia regulatedmiRNAs. A figure showing miRNA: target
gene interaction network for pathways in cancer of hESCs (a) and hMSCs (b) drawn using
Cytoscape software. The green color refers up-regulation while the red color refers down-regu-
lation.
(TIF)
S1 Table. List of upregulated (Sheet 1 and 3) and downregulated (Sheet 2 and 4) miRNAs
showing>2 fold difference in response to hypoxia in SHEF1 cells and human bonemarrow
derivedMSCs based on microarray expression profiling data.
(XLSX)
S2 Table. List of primers used for the detection of specificmiRNAs using Quantitative
RT-PCR.
(DOCX)
S3 Table. List showing location of HREs and their scores in the promoters of hypoxia
inducedmiRNAs based on python program.
(XLSX)
S4 Table. List of predicted targets of up-regulated and down-regulatedmiRNAs in hE &
MSCs using DIANA-MicroT-CDS program.
(XLSX)
S5 Table. List of analyzedpathways of hypoxia up-regulated (8a, b) and down-regulated
(8c, d) miRNAs in hE &MSCs, respectively, using DIANA-mirPath program.
(XLSX)
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